CDNA
CareDx, Inc.
Overview
CareDx, Inc is a Healthcare company operating in Diagnostics & Research with a $1.29B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 4, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-04-2820 Q&A exchanges
- Q4 FY2025Earnings2026-02-2428 Q&A exchanges
- Q3 FY2025Earnings2025-11-0419 Q&A exchanges
- Q2 FY2025Earnings2025-08-066 Q&A exchanges
- Q1 FY2025Earnings2025-04-3020 Q&A exchanges
- Q4 FY2024Earnings2025-02-2631 Q&A exchanges
- Q3 FY2024Earnings2024-11-0424 Q&A exchanges
- Q2 FY2024Earnings2024-07-3130 Q&A exchanges
- Q1 FY2024Earnings2024-05-099 Q&A exchanges
- Q4 FY2023Earnings2024-02-2827 Q&A exchanges
- Q3 FY2023Earnings2023-11-0813 Q&A exchanges
- Q2 FY2023Earnings2023-08-0815 Q&A exchanges
- Q1 FY2023Earnings2023-05-1232 Q&A exchanges
- Q4 FY2022Earnings2023-02-2727 Q&A exchanges
- Q3 FY2022Earnings2022-11-0315 Q&A exchanges
- Q2 FY2022Earnings2022-08-0717 Q&A exchanges
- Q1 FY2022Earnings2022-05-0518 Q&A exchanges
- Q4 FY2021Earnings2022-02-2422 Q&A exchanges
- Q3 FY2021Earnings2021-10-2830 Q&A exchanges
- Q2 FY2021Earnings2021-07-3024 Q&A exchanges
- Q1 FY2021Earnings2021-05-0519 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-04EPS— vs $0.23—Rev— vs ——EODHD
- Q1 FY20262026-04-28EPS$0.34 vs $0.13+100.0%Rev$117.7M vs ——EODHD
- Q4 FY20252026-03-03EPS$0.12 vs $-0.01+100.0%Rev$108.4M vs ——EODHD
- Q3 FY20252025-11-03EPS$0.28 vs $-0.08+100.0%Rev$100.1M vs ——EODHD
- Q2 FY20252025-08-05EPS$0.10 vs $-0.10+100.0%Rev$86.7M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.10 vs $0.07+46.4%Rev$84.7M vs ——EODHD
- Q4 FY20242025-02-25EPS$0.18 vs $0.15+22.0%Rev$86.6M vs ——EODHD
- Q3 FY20242024-11-03EPS$0.14 vs $0.01+100.0%Rev$82.9M vs ——EODHD
- Q2 FY20242024-07-30EPS$0.25 vs $-0.14+100.0%Rev$92.3M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.03 vs $-0.21+85.7%Rev$72.0M vs ——EODHD
- Q4 FY20232024-02-27EPS$-0.17 vs $-0.27+37.0%Rev$65.6M vs ——EODHD
- Q3 FY20232023-11-07EPS$-0.18 vs $-0.40+55.0%Rev$67.2M vs ——EODHD
- Q2 FY20232023-08-07EPS$-0.18 vs $-0.31+41.9%Rev$70.3M vs ——EODHD
- Q1 FY20232023-05-09EPS$-0.11 vs $-0.110.0%Rev$77.3M vs ——EODHD
- Q4 FY20222023-02-26EPS$-0.07 vs $-0.09+22.2%Rev$82.4M vs ——EODHD
- Q3 FY20222022-11-02EPS$-0.06 vs $-0.14+57.1%Rev$79.4M vs ——EODHD
- Q2 FY20222022-08-03EPS$-0.13 vs $-0.11-18.2%Rev$80.6M vs ——EODHD
- Q1 FY20222022-05-04EPS$-0.13 vs $-0.05-100.0%Rev$79.4M vs ——EODHD
- Q4 FY20212022-02-23EPS$-0.03 vs $0.03-100.0%Rev$79.2M vs ——EODHD
- Q3 FY20212021-10-27EPS$0.07 vs $0.01+100.0%Rev$75.6M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | — | $0.23 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-04-28 | $0.34 | $0.13 | +100.0% | $117.7M | — | — | EODHD |
| Q4 FY2025 | 2026-03-03 | $0.12 | $-0.01 | +100.0% | $108.4M | — | — | EODHD |
| Q3 FY2025 | 2025-11-03 | $0.28 | $-0.08 | +100.0% | $100.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-05 | $0.10 | $-0.10 | +100.0% | $86.7M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.10 | $0.07 | +46.4% | $84.7M | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $0.18 | $0.15 | +22.0% | $86.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-03 | $0.14 | $0.01 | +100.0% | $82.9M | — | — | EODHD |
| Q2 FY2024 | 2024-07-30 | $0.25 | $-0.14 | +100.0% | $92.3M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.03 | $-0.21 | +85.7% | $72.0M | — | — | EODHD |
| Q4 FY2023 | 2024-02-27 | $-0.17 | $-0.27 | +37.0% | $65.6M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.18 | $-0.40 | +55.0% | $67.2M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-0.18 | $-0.31 | +41.9% | $70.3M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.11 | $-0.11 | 0.0% | $77.3M | — | — | EODHD |
| Q4 FY2022 | 2023-02-26 | $-0.07 | $-0.09 | +22.2% | $82.4M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.06 | $-0.14 | +57.1% | $79.4M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.13 | $-0.11 | -18.2% | $80.6M | — | — | EODHD |
| Q1 FY2022 | 2022-05-04 | $-0.13 | $-0.05 | -100.0% | $79.4M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-0.03 | $0.03 | -100.0% | $79.2M | — | — | EODHD |
| Q3 FY2021 | 2021-10-27 | $0.07 | $0.01 | +100.0% | $75.6M | — | — | EODHD |
Source: EODHD. CDNA reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks CDNA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.20 | $2.83 | -22.1% | -2.8% | -3.1% |
| Q4 FY2026 | $2.09 | $2.98 | -29.7% | -2.2% | -2.4% |
| Q3 FY2026 | $2.14 | $2.87 | -25.6% | +1.1% | +2.5% |
| Q2 FY2026 | $2.38 | $2.94 | -19.1% | +5.0% | +6.0% |
| Q1 FY2025 | $2.29 | $3.10 | -26.1% | -5.6% | -6.6% |
| Q4 FY2025 | $2.49 | $3.12 | -20.3% | -0.1% | -0.2% |
| Q3 FY2025 | $2.14 | $3.13 | -31.7% | -3.9% | -1.9% |
| Q2 FY2025 | $2.44 | $3.09 | -20.9% | -2.7% | -2.4% |
| Q1 FY2024 | $2.26 | $3.10 | -27.2% | +5.6% | +7.3% |
| Q4 FY2024 | $2.29 | $3.04 | -24.7% | -3.9% | -1.2% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- John Walter Hanna JrCEO5 mo1 callCurrentSample
CEO since 2026 • 1/2 beats (50%) • guidance suspended Q3 FY2026
- Keith KennedyCFO2 mo5 callsCurrentSample
CFO since 2026 • 2/2 beats (100%) • last guidance cut Q1 FY2026
- Nathan SmithCFO10 mo2 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • guidance suspended Q1 FY2026
- Abhishek JainCFO10 mo13 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- Jessica MengChief Commercial Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
- Jeffrey Adam NovackSecretary and General Counsel11 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CDNA.
$ curl https://api.spokenalpha.com/v1/companies/CDNAFAQ
Frequently asked about CDNA
Where can I find CareDx, Inc.'s (CDNA) earnings call transcripts?
Spoken Alpha indexes CDNA's earnings call transcripts at https://spokenalpha.com/companies/CDNA. Each call links to attributed speakers and parsed analyst Q&A. CareDx, Inc.'s own investor relations page is at https://investors.caredx.com/.
When was CareDx, Inc.'s most recent earnings call?
CareDx, Inc. (CDNA) held its most recent earnings call on 2026-04-28, covering fiscal Q1 2026.
What sector is CDNA in?
CareDx, Inc. (CDNA) operates in the Healthcare sector (Diagnostics & Research industry).